Cairn Therapeutics, Inc. Press Releases

• Published on October 29, 2024 - 14:39 GMT

  Cairn Therapeutics Completes $4M Bridge Investment Round to Fund Startup of Phase I Clinical Trial

  WILMINGTON, DE, UNITED STATES, October 29, 2024 /⁨EINPresswire.com⁩/ -- Cairn Therapeutics, Inc., (“Cairn” or the “Company”), a pharmaceutical company developing highly targeted medications for the treatment of cancer, today announced that it has completed …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on March 28, 2024 - 19:46 GMT

  Cairn Therapeutics to Present at MedInvest Biotech & Pharma Investor Conference

  WILMINGTON, DE, USA, March 28, 2024 /⁨EINPresswire.com⁩/ -- Cairn Therapeutics, Inc., (“Cairn” or the “Company”), a pharmaceutical company developing highly targeted medications for the treatment of cancer, today announced that it will present an update on …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on December 18, 2023 - 17:52 GMT

  

  Cairn Therapeutics Announces New Management Team and Board of Directors

  Company Intends to Initiate First-in-Human Oncology Clinical Trials Next Year WILMINGTON, DE, US, December 18, 2023 /⁨EINPresswire.com⁩/ -- Cairn Therapeutics, Inc., a pharmaceutical company developing new, highly targeted medications for the treatment of …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...